cotinine has been researched along with Substance Withdrawal Syndrome in 113 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (7.08) | 18.7374 |
1990's | 34 (30.09) | 18.2507 |
2000's | 31 (27.43) | 29.6817 |
2010's | 34 (30.09) | 24.3611 |
2020's | 6 (5.31) | 2.80 |
Authors | Studies |
---|---|
Kaiver, CM; Lisdahl, KM; Montoto, KV; Stinson, EA; Sullivan, RM; Wade, NE; Wallace, AL | 1 |
Espinoza, VE; Giner, P; Liano, I; Mendez, IA; O'Dell, LE | 1 |
Janwantanakul, P; Klinsophon, T; Thaveeratitham, P | 1 |
Cole, M; Gilpin, NW; Kelley, LK; Kerr, TM; Montanari, C | 1 |
Blount, B; Brown, DC; Giovino, GA; Hendershot, TP; O'Malley, S; Swan, GE | 1 |
Lee, EJ | 1 |
Boileau, I; Di Ciano, P; Hendershot, CS; Houle, S; Lagzdins, D; Le Foll, B; Mansouri, E; Tyndale, RF; Wilson, AA | 1 |
Cox, S; Dawkins, L; Doig, M; Goniewicz, M; Kimber, C; Kośmider, L; McRobbie, H | 1 |
Kawamura, K; Morioka, I; Yamada, K | 1 |
Abreu-Villaça, Y; da Silva Gonçalves, B; Filgueiras, CC; Leal-Rocha, PH; Manhães, AC; Ribeiro-Carvalho, A | 1 |
Benowitz, NL; Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
Bowker, KA; Coleman, T; Cooper, S; Lewis, S; Vaz, LR | 1 |
Rahman, S; Roni, MA | 1 |
Carcoba, LM; Castañeda, E; Ferree, PL; Moss, DE; Natividad, LA; O'Dell, LE; Orfila, JE; Pipkin, JA; Torres, OV | 1 |
al'Absi, M; Lemieux, A; Nakajima, M | 1 |
Adriaens, K; Baeyens, F; Declerck, P; Van Gucht, D | 1 |
Bez, J; Dinter, C; Hermann, D; Hoffmann, H; Kiefer, F; Koopmann, A; Lemenager, T; Reinhard, I; Wiedemann, K; Winterer, G | 1 |
DeVito, EE; Gelernter, J; Herman, AI; Jensen, KP; Sofuoglu, M; Valentine, GW | 1 |
Berlin, I; Heishman, SJ; Singleton, EG | 1 |
Braida, D; Cannazza, G; Castellana, CN; Clementi, F; Fasoli, F; Gallesi, G; Gotti, C; Lucini, V; Moretti, M; Mucchietto, V; Ponzoni, L; Sala, M; Zoli, M | 1 |
al'Absi, M; Allen, S; Hatsukami, DK; Lemieux, A; Nakajima, M | 1 |
Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Kaufmann, A; Leone, FT; Powers, L; Schnoll, RA; Tyndale, RF; Veluz-Wilkins, A | 1 |
Ahmed, MS; Clark, SM; Feinn, RS; Fokina, VM; Hankins, GDV; Jain, SK; Nanovskaya, TN; Oncken, C; West, H | 1 |
Cox, CM; Faulkner, P; Ghahremani, DG; Hellemann, GS; Kazanjian, AS; London, ED; Lotfipour, S; Paterson, N; Petersen, N; Tyndale, RF; Vigil, C | 1 |
Bagdas, D; Damaj, MI; Elhassan, S | 1 |
Auerback, GM; Benowitz, NL; Moscicki, AB; Rubinstein, ML | 1 |
Mooney, M; O'Malley, SS; Sofuoglu, M; Waters, AJ | 1 |
Dent, LA; Harris, KJ; Noonan, CW | 1 |
Abreu-Villaça, Y; Filgueiras, CC; Lima, CS; Manhães, AC; Medeiros, AH; Ribeiro-Carvalho, A; Siqueira, NR | 1 |
Billes, SK; Dunayevich, E; Erickson, JS; Katz, BB; Oskooilar, N; Tollefson, G; Wilcox, CS | 1 |
Allen, AM; Allen, SS; Lunos, S; Pomerleau, CS | 1 |
Bauzo, RM; Bishnoi, M; Bruijnzeel, AW; Derendorf, H; Keijzers, KF; Kobeissy, FH; Sabarinath, SN; Shah, HP; Small, E; van Tuijl, IA; Yamada, H | 1 |
Hajek, P; McRobbie, H; Taylor, T | 1 |
Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I | 1 |
Chan, V; Doan, A; Gehricke, JG; Hong, N; Wigal, TL | 1 |
Kaplan, GB; Reid, N; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
Dhanji, AR; Hajek, P; McRobbie, HJ; Myers, KE; Stapleton, J | 1 |
Hajek, P; McRobbie, H; West, O | 1 |
Astarita, G; Caprioli, G; Ciccocioppo, R; Cippitelli, A; Duranti, A; Kallupi, M; Piomelli, D; Rodrìguez de Fonseca, F; Sagratini, G; Stopponi, S; Ubaldi, M | 1 |
Herman, AI; Jatlow, P; Nadim, H; Sofuoglu, M | 1 |
Denlinger, RL; Donny, EC; Sweitzer, MM | 1 |
Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ | 1 |
Evans, SE; Hoffman, AC | 1 |
Abreu-Villaça, Y; de Carvalho Graça, AC; Filgueiras, CC; Manhães, AC; Naiff, Vde F; Ribeiro-Carvalho, A | 1 |
Higgins, ST; O'Neill, SC; Tidey, JW | 1 |
Bye, A; Milleri, S; Squassante, L; Teneggi, V; Tiffany, ST; Ziviani, L | 1 |
al'Absi, M; Crouse, B; Erickson, J; Hatsukami, D; Wittmers, LE | 1 |
Marrocco, RT; Shirtcliff, EA | 1 |
Busto, UE; Cárdenas, L; Corrigall, WA; MacDonald, A | 1 |
Cort, N; Haustein, H; Haustein, KO; Krause, J; Rasmussen, T | 1 |
Brauer, LH; Hatsukami, DK; Jensen, J; Mooney, M; Pentel, PR; Schulte, S; Sofuoglu, M | 1 |
Cooney, JL; Cooney, NL; Kranzler, HR; Oncken, CA; Pilkey, DT | 1 |
Bonnier, C; Fiasse, L; Galanti, L; Godding, V; Lebecque, P; Longueville, E; Michel, M; Robert, A | 1 |
al'Absi, M; Davis, GL; Hatsukami, D; Wittmers, LE | 1 |
Bremann, L; Hvidberg, S; Nilsson, F; Pisinger, C; Thomsen, C; Tønnesen, P; Wennike, P; Westin, A | 1 |
Lee, HJ; Lee, JH | 1 |
Bruijnzeel, AW; Goldberger, BA; Koob, GF; Markou, A; Merves, ML; O'Dell, LE; Parsons, LH; Richardson, HN; Smith, RT | 1 |
Breland, AB; Eissenberg, T; Kleykamp, BA | 1 |
Hahn, EJ; Kelly, T; Okoli, CT | 1 |
Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
Augustson, EM; Benowitz, NL; Mabry, PL; Malcolm, RJ; Moser, RP; Tooze, JA | 1 |
Calderón-Ezquerro, C; Drucker-Colín, R; Moreno-Coutiño, A | 1 |
Budney, AJ; Hughes, JR; Liguori, A; Vandrey, RG | 1 |
al'Absi, M; Shaw, D | 1 |
Fertig, JB; Pomerleau, OF; Shanahan, SO | 1 |
Baker, TB; Croghan, IT; Fiore, MC; Hays, JT; Hurt, RD; Jorenby, DE; Lewis, SF; Offord, KP; Smith, SS | 1 |
Croghan, IT; Dale, LC; Hurt, RD; Lawson, GM; Offord, KP; Schroeder, DR | 1 |
Burling, TA; Gaither, DE; Seidner, AL | 1 |
Lumley, MA; Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
Balabanova, S; Krupienski, M | 1 |
Fagerström, KO; Lunell, E; Schneider, NG | 1 |
Leischow, SJ; Sachs, DP; Säwe, U | 1 |
Grillo, MA; Hatsukami, DK; Keenan, RM; Pentel, PR; Thompson, TN | 1 |
Caldwell, CC; Dale, LC; Fredrickson, PA; Hurt, RD; Lauger, GG; Lee, GA; Lundberg, TG; Marŭsić, Z; Neese, LW; Offord, KP | 1 |
Baker, TB; Fiore, MC; Jorenby, DE; Kenford, SL; Smith, SS; Wetter, DW | 1 |
Baskin, LB; Dale, LC; Hauri, PJ; Hurt, RD; Jiang, NS; Lauger, GG; Lawson, GM; Offord, KP | 1 |
Nørregaard, J; Petersen, L; Tønnesen, P | 1 |
Nørregaard, J; Säwe, U; Simonsen, K; Tønnesen, P | 1 |
Colligan, RC; Croghan, IT; Gauvin, TR; Gomez-Dahl, LC; House, RF; Hurt, RD; Offord, KP; Smith, TA | 1 |
Butschky, MF; Fant, RV; Henningfield, JE; Pickworth, WB | 1 |
Bättig, K; Hasenfratz, M; Kos, J | 1 |
Berlin, I; Launay, JM; Saïd, S; Spreux-Varoquaux, O | 1 |
Bliss, R; Grillo, M; Hatsukami, DK; Oncken, C; Pentel, PR | 1 |
Croghan, GA; Croghan, IT; Dale, LC; Gomez-Dahl, LC; Hurt, RD; Offord, KP | 1 |
Haydel, KF; Killen, JD; Robinson, TN; Rojas, NL | 1 |
Allen, SS; Goldman, A; Hatsukami, D; Jensen, J; Nelson, D; Pentel, PR; Rafael, D | 1 |
Fagerström, KO; Lunell, E; Tejding, R; Westin, A | 1 |
Alterman, AI; Barber, W; Bedi, N; Cnaan, A; Gariti, P; Luck, G | 1 |
Albrecht, SA; Braxter, B; Cassidy, B; Cornelius, MD; Reynolds, MD; Stone, C | 1 |
Forbes, A; Gourlay, SG; Marriner, T; McNeil, JJ | 1 |
Fisher, H; Halladay, AK; Iba, MM; Schwartz, M; Sekowski, A; Wagner, GC | 1 |
Ahtee, L; Gäddnäs, H; Salminen, O; Seppä, T | 1 |
Croghan, IT; Hurt, RD; Moyer, TP; Offord, KP; Ogburn, PL; Ramin, KD; Schroeder, DR | 1 |
Djurić, VJ; Dragomir, A; Dunn, E; Overstreet, DH; Steiner, M | 1 |
Beede, SD; Croghan, GA; Croghan, IT; Hurt, RD; Patten, CA; Wolter, TD | 1 |
Colby, SM; Niaura, RS; Shiffman, S; Tiffany, ST | 1 |
Wiseman, EJ | 1 |
Galvin, K; Hillier, V; Webb, C | 1 |
Domino, EF; Guthrie, S; Koeppe, RA; Lombardi, U; Minoshima, S; Ni, L; Ohl, LE; Zubieta, J | 1 |
Eliasson, B; Hjalmarson, A; Kruse, E; Landfeldt, B | 1 |
Anton, D; Callies, A; Hatsukami, D; Keenan, R | 1 |
Hatsukami, DK; Huber, M; Hughes, J; Skoog, K | 1 |
Lando, HA; McGovern, PG | 1 |
Kloska, DD; Majchrzak, MJ; Malakuti, R; Pomerleau, CS; Pomerleau, OF | 1 |
Fenwick, JW; Gust, SW; Hughes, JR; Keenan, RM | 1 |
Anton, DJ; Hatsukami, DK; Keenan, RM | 1 |
Andersson, K; Eneroth, P; Fuxe, K; Härfstrand, A; Jansson, A | 1 |
Asencio, M; Carroll, ME; Keenan, RM; Lac, ST | 1 |
Bryant, A; Jackson, P; Jarvis, M; McNeill, AD; West, RJ | 1 |
Gust, SW; Hatsukami, DK; Keenan, RM | 1 |
Hall, SM; Killen, JD | 1 |
Hatsukami, DK; Hughes, JR; Pickens, RW | 1 |
4 review(s) available for cotinine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.
Topics: Cotinine; Humans; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Abuse potential of non-nicotine tobacco smoke components: acetaldehyde, nornicotine, cotinine, and anabasine.
Topics: Acetaldehyde; Anabasine; Animals; Cotinine; Dopamine; Humans; Mesencephalon; Nicotine; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Secondhand smoke and nicotine exposure: a brief review.
Topics: Adolescent; Adult; Biomarkers; Cotinine; Environmental Exposure; Female; Hair; Humans; Male; Mental Disorders; Nicotine; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 2007 |
Are adolescent smokers dependent on nicotine? A review of the evidence.
Topics: Adolescent; Adult; Cotinine; Female; Humans; Male; Nicotiana; Plants, Toxic; Prevalence; Risk Factors; Sex Factors; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
49 trial(s) available for cotinine and Substance Withdrawal Syndrome
Article | Year |
---|---|
The effect of three-part breathing exercise on smoking cessation: A 6-month cluster-randomized clinical trial.
Topics: Breathing Exercises; Cotinine; Humans; Nicotine; Quality of Life; Smoking Cessation; Substance Withdrawal Syndrome; Thailand | 2022 |
Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Humans; Nicotine; Pregnancy; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2014 |
Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints.
Topics: Adult; Belgium; Biomarkers; Carbon Dioxide; Cotinine; Craving; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers.
Topics: Adult; Cotinine; Double-Blind Method; Female; Follow-Up Studies; Humans; Pregnancy; Reproducibility of Results; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2016 |
Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Breath Tests; Bupropion; Carbon Dioxide; Cotinine; Counseling; Delayed-Action Preparations; Double-Blind Method; Exhalation; Female; Humans; Pregnancy; Prospective Studies; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.
Topics: Adult; Affect; Anti-Infective Agents; Attention; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Minocycline; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2009 |
Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation.
Topics: Bupropion; Community Pharmacy Services; Cotinine; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2009 |
An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.
Topics: Adult; Bupropion; Cotinine; Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Obesity; Overweight; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 2010 |
Severity of withdrawal symptomatology in follicular versus luteal quitters: The combined effects of menstrual phase and withdrawal on smoking cessation outcome.
Topics: Adolescent; Adult; Biomarkers; Carbon Monoxide; Cotinine; Female; Follicular Phase; Humans; Luteal Phase; Recurrence; Saliva; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2010 |
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult | 2011 |
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.
Topics: Adult; Behavior Therapy; Behavior, Addictive; Breath Tests; Bupropion; Carbon Monoxide; Combined Modality Therapy; Cotinine; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Patient Dropouts; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Topics: Adult; Benzazepines; Biomarkers; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; London; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline | 2011 |
Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.
Topics: Adolescent; Adult; Analysis of Variance; Carbon Monoxide; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cotinine; Dose-Response Relationship, Drug; Heart Rate; Humans; Hydrocortisone; Injections, Intravenous; Male; Middle Aged; Nicotine; Nicotinic Agonists; Single-Blind Method; Substance Withdrawal Syndrome; Tandem Mass Spectrometry; Time Factors; Young Adult | 2012 |
Dependence and withdrawal-induced craving predict abstinence in an incentive-based model of smoking relapse.
Topics: Adult; Cotinine; Female; Humans; Male; Middle Aged; Patient Compliance; Reinforcement, Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2013 |
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult | 2012 |
Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Breath Tests; Carbon Monoxide; Cotinine; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Substance Withdrawal Syndrome; Tobacco Use Cessation | 2002 |
Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Random Allocation; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2002 |
Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers.
Topics: Adrenal Cortex; Adult; Affect; Blood Pressure; Caffeine; Central Nervous System Stimulants; Cotinine; Female; Heart Rate; Humans; Hydrocortisone; Male; Saliva; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2003 |
Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Psychotropic Drugs; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males.
Topics: Administration, Cutaneous; Adult; Blood Gas Monitoring, Transcutaneous; Carbon Monoxide; Cardiovascular Diseases; Cholesterol; Cotinine; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Risk Factors; Smoking; Substance Withdrawal Syndrome; Thiocyanates; Triglycerides | 2003 |
Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine.
Topics: Administration, Cutaneous; Adult; Behavior; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Hemodynamics; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation; Treatment Outcome | 2003 |
Effects of smoking cessation and reduction in asthmatics.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Carbon Monoxide; Chewing Gum; Chi-Square Distribution; Cotinine; Denmark; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Prospective Studies; Quality of Life; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thiocyanates; Time Factors | 2005 |
Effects of medicinal herb tea on the smoking cessation and reducing smoking withdrawal symptoms.
Topics: Adult; Antioxidants; Beverages; Cells, Cultured; Cotinine; Drugs, Chinese Herbal; Humans; Liver; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Taste; Treatment Outcome | 2005 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Varying nicotine patch dose and type of smoking cessation counseling.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
Topics: Administration, Cutaneous; Adult; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1995 |
Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.
Topics: Administration, Cutaneous; Chewing Gum; Combined Modality Therapy; Cotinine; Double-Blind Method; Humans; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Cotinine; Delayed-Action Preparations; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Psychotherapy, Group; Smoking; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1993 |
Pharmacodynamic effects of cotinine in abstinent cigarette smokers.
Topics: Adult; Affect; Cotinine; Double-Blind Method; Humans; Injections, Intravenous; Male; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Topics: Administration, Cutaneous; Adult; Aged; Breath Tests; Carbon Monoxide; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nurses; Physician's Role; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches.
Topics: Administration, Cutaneous; Adult; Aged; Chi-Square Distribution; Cotinine; Female; Follow-Up Studies; Forecasting; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome and Process Assessment, Health Care; Patient Compliance; Placebos; Prospective Studies; Regression Analysis; Saliva; Self-Assessment; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Time Factors; Weight Gain | 1993 |
Recycling with nicotine patches in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Nicotine patch therapy in adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cotinine; Female; Follow-Up Studies; Humans; Male; Minnesota; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Urban Population | 1996 |
Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Cognition; Cotinine; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Humans; Male; Nicotiana; Nicotine; Plants, Toxic; Psychomotor Performance; Substance Withdrawal Syndrome | 1996 |
Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers.
Topics: Adult; Anxiety; Biogenic Monoamines; Cotinine; Depressive Disorder; Female; Humans; Isoenzymes; Male; Monoamine Oxidase; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1997 |
Safety of cotinine in humans: physiologic, subjective, and cognitive effects.
Topics: Adult; Cognition; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Individuality; Liver Function Tests; Male; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1997 |
Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Topics: Administration, Inhalation; Adult; Aged; Body Weight; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Nasal Mucosa; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1998 |
Cotinine: effects with and without nicotine.
Topics: Administration, Topical; Adult; Affect; Blood Pressure; Cotinine; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
Topics: Adult; Carbon Monoxide; Cotinine; Cross-Over Studies; Female; Humans; Infant; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 1997 |
Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.
Topics: Administration, Cutaneous; Adult; Biomarkers; Chi-Square Distribution; Cholinergic Agents; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 1999 |
An assessment of nicotine dependence among pregnant adolescents.
Topics: Adolescent; Adult; Black or African American; Cotinine; Data Interpretation, Statistical; Female; Humans; Pregnancy; Pregnancy in Adolescence; Psychological Tests; Psychology, Adolescent; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States; White People | 1999 |
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Topics: Administration, Cutaneous; Adolescent; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2000 |
Assessing the impact of a nurse-led health education intervention for people with peripheral vascular disease who smoke: the use of physiological markers, nicotine dependence and withdrawal.
Topics: Aged; Biomarkers; Breath Tests; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nurse Clinicians; Nursing Evaluation Research; Patient Education as Topic; Peripheral Vascular Diseases; Program Evaluation; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2001 |
Smokeless tobacco abstinence effects and nicotine gum dose.
Topics: Adult; Carbon Monoxide; Chewing Gum; Cotinine; Double-Blind Method; Humans; Nicotine; Plants, Toxic; Reaction Time; Saliva; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 1992 |
Signs and symptoms from nicotine gum abstinence.
Topics: Adult; Chewing Gum; Cotinine; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Reduced nicotine exposure and abstinence outcome in two nicotine fading methods.
Topics: Adult; Behavior Therapy; Breath Tests; Carbon Monoxide; Cotinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking; Substance Withdrawal Syndrome | 1991 |
Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
Topics: Adult; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotine; Random Allocation; Saliva; Self Administration; Smoking Prevention; Substance Withdrawal Syndrome | 1990 |
The effects of short-term smokeless tobacco deprivation on performance.
Topics: Adult; Affect; Cotinine; Heart Rate; Humans; Male; Nicotiana; Plants, Toxic; Psychomotor Performance; Reaction Time; Substance Withdrawal Syndrome; Tobacco, Smokeless | 1989 |
60 other study(ies) available for cotinine and Substance Withdrawal Syndrome
Article | Year |
---|---|
Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
Topics: Adolescent; Cannabinoid Receptor Agonists; Cannabis; Cotinine; Cross-Sectional Studies; Hallucinogens; Humans; Marijuana Abuse; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Young Adult | 2022 |
Sex and age differences in approach behavior toward a port that delivers nicotine vapor.
Topics: Animals; Anxiety; Choice Behavior; Cotinine; Female; Male; Nicotine; Rats; Substance Withdrawal Syndrome | 2022 |
Nicotine e-cigarette vapor inhalation effects on nicotine & cotinine plasma levels and somatic withdrawal signs in adult male Wistar rats.
Topics: Administration, Inhalation; Age Factors; Animals; Atmosphere Exposure Chambers; Cotinine; Dose-Response Relationship, Drug; Electronic Nicotine Delivery Systems; Male; Medically Unexplained Symptoms; Nicotine; Random Allocation; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Vaping | 2020 |
PhenX: Host: Biobehavioral measures for tobacco regulatory research.
Topics: Adolescent; Adult; Advisory Committees; Carbon Dioxide; Consensus; Cotinine; Cues; Data Collection; Female; Humans; Male; Nitrosamines; Phenotype; Pregnancy; Research Design; Smokers; Smoking; Software; Substance Withdrawal Syndrome; Tobacco Use | 2020 |
Factors Predicting 6-Month Smoking Cessation in Korean Adults.
Topics: Adult; Cotinine; Female; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Prognosis; Republic of Korea; Resilience, Psychological; Serotonin; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2020 |
Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
Topics: Adult; Brain; Carbon Isotopes; Cotinine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nicotine; Nicotinic Agonists; Oxazines; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder | 2018 |
'Real-world' compensatory behaviour with low nicotine concentration e-liquid: subjective effects and nicotine, acrolein and formaldehyde exposure.
Topics: Acetylcysteine; Acrolein; Adult; Cotinine; Craving; England; Female; Formaldehyde; Formates; Humans; Inhalation Exposure; Male; Middle Aged; Nicotine; Nicotinic Agonists; Saliva; Substance Withdrawal Syndrome; Vaping; Young Adult | 2018 |
[Health Effects Accompanying the Transition from Cigarettes to Heat-not-burn Tobacco: Nicotine Dependence, Nicotine Withdrawal Symptoms, and Changes in Smoking Behaviors].
Topics: Acetaldehyde; Adult; Ammonia; Breath Tests; Carbon Monoxide; Cotinine; Dust; Formaldehyde; Humans; Male; Middle Aged; Nicotiana; Nicotine; Saliva; Smoke; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Young Adult | 2018 |
Lifelong exposure to caffeine increases anxiety-like behavior in adult mice exposed to tobacco smoke during adolescence.
Topics: Aging; Animals; Anxiety; Behavior, Animal; Caffeine; Cotinine; Exploratory Behavior; Female; Male; Mice; Nicotiana; Nicotine; Substance Withdrawal Syndrome | 2019 |
Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study.
Topics: Adult; Affect; Anxiety; Attention; Cotinine; Craving; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cotinine; Cyclic AMP Response Element-Binding Protein; Depression; Disease Models, Animal; Hippocampus; Lobeline; Male; Mice, Inbred C57BL; Motor Activity; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Norepinephrine; Prefrontal Cortex; Receptors, Nicotinic; Substance Withdrawal Syndrome; Swimming; Tobacco Use Disorder | 2014 |
Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Cotinine; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Parasympathetic Nervous System; Rats; Rats, Wistar; Smoking; Substance Withdrawal Syndrome; Synaptic Transmission | 2014 |
Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers.
Topics: Adult; Carbon Monoxide; Cotinine; Craving; Female; Ghrelin; Humans; Male; Peptide YY; Recurrence; Risk Factors; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2014 |
Effects of Cigarette Smoking on Plasma Concentration of the Appetite-Regulating Peptide Ghrelin.
Topics: Acetylation; Adult; Cotinine; Female; Ghrelin; Humans; Male; Nicotine; Postprandial Period; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2015 |
A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Topics: Adult; Blood Pressure; Cognition Disorders; Cotinine; Female; Genome-Wide Association Study; Heart Rate; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.
Topics: Animals; Body Weight; Brain; Cotinine; Disease Models, Animal; Eating; Electronic Nicotine Delivery Systems; Emotions; Male; Mecamylamine; Memory, Short-Term; Mice, Inbred BALB C; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Respiration, Artificial; Spatial Memory; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Tobacco Use Disorder | 2015 |
Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse.
Topics: Adult; Carbon Monoxide; Cotinine; Craving; Female; Humans; Leptin; Male; Nicotine; Nicotinic Agonists; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Topics: Administration, Cutaneous; Analysis of Variance; Anxiety; Biomarkers; Cotinine; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects.
Topics: Adolescent; Adult; Affect; Attention; Consumer Behavior; Cotinine; Craving; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Smoking; Substance Withdrawal Syndrome; Young Adult | 2017 |
Effects of Nicotine Metabolites on Nicotine Withdrawal Behaviors in Mice.
Topics: Animals; Anxiety; Behavior, Animal; Cotinine; Male; Mice; Mice, Inbred ICR; Nicotine; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers.
Topics: Adolescent; Air; Breath Tests; California; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Combined exposure to nicotine and ethanol in adolescent mice: effects on the central cholinergic systems during short and long term withdrawal.
Topics: Age Factors; Animals; Biomarkers; Body Weight; Brain; Choline O-Acetyltransferase; Cotinine; Drinking; Drug Interactions; Ethanol; Female; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nicotine; Protein Binding; Radioligand Assay; Receptors, Nicotinic; Substance Withdrawal Syndrome; Synapses; Time Factors | 2009 |
Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Weight; Cotinine; Electric Stimulation; Environmental Exposure; Male; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reaction Time; Reward; Self Stimulation; Sexual Maturation; Substance Withdrawal Syndrome; Time Factors; Tobacco Smoke Pollution; Tobacco Use Disorder | 2010 |
The effect of stopping smoking on perceived stress levels.
Topics: Adaptation, Psychological; Adolescent; Attitude to Health; Coronary Artery Bypass; Cotinine; Female; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Perception; Regression Analysis; Saliva; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2010 |
ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cotinine; Female; Humans; Male; Placebos; Substance Withdrawal Syndrome | 2011 |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cotinine; Endocannabinoids; Glycerides; Implants, Experimental; Locomotion; Male; Maze Learning; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Weight Gain | 2011 |
Combined exposure to tobacco smoke and ethanol in adolescent mice elicits memory and learning deficits both during exposure and withdrawal.
Topics: Age Factors; Animals; Behavior, Animal; Body Weight; Cotinine; Ethanol; Female; Learning; Male; Memory, Long-Term; Memory, Short-Term; Mice; Smoking; Substance Withdrawal Syndrome | 2013 |
Salivary cotinine levels in human tobacco smokers predict the attentional validity effect size during smoking abstinence.
Topics: Adult; Attention; Cotinine; Cues; Eye Movements; Humans; Indicators and Reagents; Nicotiana; Psychomotor Performance; Reaction Time; Reproducibility of Results; Saliva; Salivation; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers.
Topics: Adult; Alcoholism; Breath Tests; Carbon Monoxide; Cotinine; Cues; Female; Humans; Imagery, Psychotherapy; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Salivation; Smoking; Substance Withdrawal Syndrome | 2003 |
Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates?
Topics: Adult; Cotinine; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Nervous System Diseases; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse.
Topics: Adolescent; Adult; Affect; Aged; Area Under Curve; Carbon Monoxide; Circadian Rhythm; Cotinine; Female; Humans; Hydrocortisone; Male; Middle Aged; Saliva; Secondary Prevention; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2004 |
[Recommendation of good practice: Therapeutic strategies, with or without the assistance of medicine-based treatment, for stopping smoking (May 2003)].
Topics: Adolescent; Alcohol Drinking; Bupropion; Cotinine; Female; Humans; MEDLINE; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.
Topics: Age Factors; Animals; Behavior, Animal; Cotinine; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Sensory Thresholds; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Clinical laboratory evaluation of potential reduced exposure products for smokers.
Topics: Adult; Biomarkers; Carbon Monoxide; Carcinogens; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Respiratory Function Tests; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
Topics: Administration, Intranasal; Adult; Algorithms; Black or African American; Cotinine; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Ganglionic Stimulants; Humans; Male; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Long-term changes in sleep and depressive symptoms of smokers in abstinence.
Topics: Adult; Cotinine; Depression; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Mexico; Middle Aged; Nicotine; Polysomnography; Sleep Initiation and Maintenance Disorders; Sleep, REM; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances.
Topics: Adolescent; Adult; Aggression; Alcohol Drinking; Analysis of Variance; Anger; Attention; Cannabinoids; Cannabis; Cotinine; Drug Interactions; Female; Humans; Irritable Mood; Male; Nicotiana; Psychiatric Status Rating Scales; Sleep; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Attenuated beta endorphin response to acute stress is associated with smoking relapse.
Topics: Acute Disease; Adult; beta-Endorphin; Cotinine; Data Interpretation, Statistical; Female; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Performance; Recurrence; Risk; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2008 |
Nicotine dependence in cigarette smoking: an empirically-based, multivariate model.
Topics: Cotinine; Drug Tolerance; Heart Rate; Humans; Male; Models, Psychological; Nicotine; Skin Temperature; Smoking; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Tobacco Use Disorder | 1983 |
A computer-directed program for smoking cessation treatment.
Topics: Cotinine; Drug Administration Schedule; Follow-Up Studies; Health Promotion; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation; Software; Substance Withdrawal Syndrome; Treatment Outcome; Workplace | 1994 |
Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms.
Topics: Adult; Cotinine; Female; Humans; Male; Neurologic Examination; Nicotine; Prospective Studies; Retrospective Studies; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
[Detection of nicotine in eccrine sweat after stimulation of sweat glands during nicotine withdrawal].
Topics: Adolescent; Adult; Cotinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nicotine; Pilocarpine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 1995 |
Serum nicotine and cotinine levels during nicotine-patch therapy.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome | 1993 |
Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers.
Topics: Adult; Aged; Aging; Arousal; Blood Pressure; Body Weight; Cotinine; Energy Intake; Female; Food Preferences; Heart Rate; Humans; Middle Aged; Nicotine; Problem Solving; Reaction Time; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1997 |
Nicotine dependence among adolescent smokers.
Topics: Adolescent; Cotinine; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Male; Nicotine; Prevalence; Psychological Tests; Saliva; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Cohort Studies; Cotinine; Erythema; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Severity of Illness Index; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Efficacy of providing nicotine in a liquid diet to rats.
Topics: Administration, Oral; Animals; Body Weight; Cotinine; Diet; Eating; Male; Motor Activity; Nicotine; Psychotropic Drugs; Rats; Rats, Long-Evans; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Caudate Nucleus; Corpus Striatum; Cotinine; Dopamine; Drug Administration Schedule; Gyrus Cinguli; Homovanillic Acid; Immunohistochemistry; Infusions, Parenteral; Injections, Subcutaneous; Limbic System; Male; Niacin; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1999 |
Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Fetus; Heart Rate, Fetal; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines.
Topics: Animals; Antidepressive Agents; Cotinine; Depressive Disorder; Drinking; Female; Nicotine; Nicotinic Agonists; Rats; Rats, Inbred Strains; Species Specificity; Substance Withdrawal Syndrome; Swimming; Weight Gain | 1999 |
Nicotine dependence and withdrawal in cocaine-dependent patients.
Topics: Cocaine-Related Disorders; Comorbidity; Cotinine; Creatinine; Humans; Models, Statistical; Patient Selection; Psychomotor Performance; Research Design; Smoking; Substance Abuse Detection; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers.
Topics: Adolescent; Adult; Brain; Cerebrovascular Circulation; Circadian Rhythm; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Substance Withdrawal Syndrome; Temporal Lobe; Thalamus; Tomography, Emission-Computed | 2001 |
Effect of smoking reduction and cessation on cardiovascular risk factors.
Topics: Adult; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Lipoproteins, HDL; Male; Nicotine; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Triglycerides | 2001 |
Relationship between nicotine tolerance questionnaire scores and plasma cotinine.
Topics: Adult; Arousal; Cotinine; Drug Tolerance; Female; Humans; Male; Nicotine; Personality Tests; Pyrrolidinones; Risk Factors; Smoking; Substance Withdrawal Syndrome | 1990 |
Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat.
Topics: Animals; Catecholamines; Corticosterone; Cotinine; Hypothalamus; Male; Nerve Endings; Nicotine; Norepinephrine; Pituitary Hormones; Preoptic Area; Rats; Rats, Inbred Strains; Smoking; Substance Withdrawal Syndrome; Testosterone; Thyrotropin | 1989 |
Nicotine dependence in rats.
Topics: Animals; Behavior, Animal; Cotinine; Drinking Behavior; Feeding Behavior; Nicotine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1989 |
Cigarette withdrawal symptoms in adolescent smokers.
Topics: Adolescent; Child; Cotinine; Female; Humans; Probability; Regression Analysis; Saliva; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1986 |
Physiologic and subjective changes from smokeless tobacco withdrawal.
Topics: Adult; Cotinine; Humans; Male; Nicotiana; Plants, Toxic; Saliva; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Tobacco, Smokeless | 1987 |
Psychological and pharmacological approaches to smoking relapse prevention.
Topics: Adult; Chewing Gum; Cotinine; Female; Humans; Male; Nicotine; Recurrence; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1985 |
Blood nicotine, smoke exposure and tobacco withdrawal symptoms.
Topics: Adult; Confusion; Cotinine; Female; Humans; Male; Nicotine; Sleep Wake Disorders; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1985 |